| Health Care Equipment & Supplies Industry | Healthcare Sector | - CEO | KRX SM Exchange | KR7253840003 ISIN |
| KR Country | 144 Employees | 28 Dec 2022 Last Dividend | 7 Dec 2018 Last Split | - IPO Date |
Sugentech Inc., originally known as Accugen Healthcare, Inc., underwent a name change in October 2013 and has been operating under its new identity since then. Founded in 2011 and headquartered in Daejeon, South Korea, the company positions itself at the confluence of biotechnology, information technology, and nanotechnology. With a global reach, Sugentech Inc. specializes in developing and distributing in-vitro diagnostic systems and products. These innovations are designed to meet a variety of healthcare needs, from disease diagnostics to self-testing solutions, leveraging modern technology to deliver accurate results.
Sugentech Inc. offers a diverse portfolio of products and services, each tailored to address specific diagnostic and testing needs: